home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Meeting Today’s FDA Requirements for Clinical Trial Processes

 
  March 09, 2009  
     
 
The Center for Professional Advancement, 90 Minute Accredited Online Training
April 28, 2009 at 11:00 a.m. - 12:30 p.m. (EST)


Who Should Attend
This course is designed for professionals within the pharmaceutical and biologics industries who are interested in the planning and submissions of INDs. The training will be especially valuable to:

  • Regulatory Personnel 
  • QA Managers
  • Directors and VPs 
  • Representatives of Contract Research Organizations 
    (CROs)

Description
The FDA procedures for the clinical testing of drugs, potentially leading to the filing of an NDA or ANDA, are evolving rapidly. This 90-minute accredited program examines the steps involved in designing and filing for permission to conduct the clinical tests (the IND) and the FDA issues and concerns in reviewing IND applications.

Module 1: Overview: Clinical Testing Concerns
  • QbD
  • Post marketing clinical testing
  • Phases of Clinical Testing

Module 2: Steps
  • Planning the Clinical Testing Process
  • Pre-clinical
  • IND filing
  • Pre-meeting
  • Design
  • Research
  • Investigator's Brochure
  • IRB approval
  • Format

Module 3: FDA Criteria and Concerns
  • Foreign studies
  • Design issues
  • Safety and IRB review
  • Study Size
  • Blood/brain barrier

Question and Answer Session

 
 
Organized by: The Center for Professional Advancement
Invited Speakers: Dr. Sandy Weinberg, Independent Consultant to the FDA

Dr. Sandy Weinberg is an Associate Professor of Health Care Management (Regulation) at Clayton State University, part of the Georgia State University System; a retired regulatory professional from the drug, device, and vaccine industries; and a consultant with more than twenty-five years of experience. He is the author of Guidebook to Drug Regulatory Submissions (Wiley, 2008).
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: salbers@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.